×
About 345 results

ALLMedicine™ Pituitary Macroadenomas Center

Research & Reviews  130 results

Prolactin at moderately increased levels confers a neuroprotective effect in non-secret...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348739
PloS One; Paul DA, Rodrigue A et. al.

Aug 4th, 2022 - Prolactin, a hormone synthesized by the anterior pituitary gland demonstrates promise as a neuroprotective agent, however, its role in humans and in vivo during injury is not fully understood. To investigate whether elevated levels of prolactin at...

Utilization of iMRI for Transsphenoidal Resection of Pituitary Macroadenomas
https://clinicaltrials.gov/ct2/show/NCT02396810

Jul 19th, 2022 - The investigators are studying the utility of intra-operative magnetic resonance imaging (iMRI) during transsphenoidal pituitary surgery for large macroadenomas by randomizing patients to either an intra-operative MRI after resection, or no intra-...

Do We Need Gadolinium-Based Contrast Agents for Routine MRI Surveillance of Unoperated ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262062
AJNR. American Journal of Neuroradiology; Alali AA, Hanagandi PB et. al.

Jun 24th, 2022 - The use of gadolinium-based contrast agents contributes to the cost of MR imaging and prolongs image-acquisition time. There are also recent concerns regarding gadolinium deposition, particularly in patients who require frequent follow-up MRIs. Th...

Changes in the peripapillary and subfoveal choroidal vascularity index after transsphen...
https://doi.org/10.1007/s10792-022-02366-7
International Ophthalmology; Özcan Y, Kayıran A et. al.

May 24th, 2022 - To investigate the changes in peripapillary and subfoveal choroidal vascular indexes (CVI) before and after pituitary macroadenoma surgery by using a binarization method. In this cross-sectional study, we examined 17 eyes in 9 patients with pituit...

Detection of a pituitary macroadenoma with transcranial ultrasonography: Principles and...
https://doi.org/10.1002/jcu.23156
Journal of Clinical Ultrasound : JCU; Meini S, Andreini R et. al.

Feb 16th, 2022 - Transcranial color-coded duplex sonography (TCCS) allows to study intracranial vessels through the intact skull, but the visualization of normal and pathologic brain structures in adults is often suboptimal due to inadequate acoustic window. The f...

see more →

Clinicaltrials.gov  7 results

Utilization of iMRI for Transsphenoidal Resection of Pituitary Macroadenomas
https://clinicaltrials.gov/ct2/show/NCT02396810

Jul 19th, 2022 - The investigators are studying the utility of intra-operative magnetic resonance imaging (iMRI) during transsphenoidal pituitary surgery for large macroadenomas by randomizing patients to either an intra-operative MRI after resection, or no intra-...

Radioactive Iodine Implants for Pan-invasive Pituitary Macroadenomas
https://clinicaltrials.gov/ct2/show/NCT01444209

Nov 30th, 2021 - This study is a single arm Phase II pilot trial. Patients enrolled on the trial will undergo implantation of high activity iodine-125 seeds into their pituitary adenoma. The tumor response to treatment will be monitored as well as change in visual...

Visual Outcome After Transsphenoidal Surgery for Pituitary Macroadenoma
https://clinicaltrials.gov/ct2/show/NCT03363126

Dec 6th, 2017 - Endoscopic endonasal transsphenoidal surgery is a procedure for the treatment of pituitary macroadenomas that cause visual impairment through optic chiasm compression. The aim of this retrospective study is to describe visual outcome after this pr...

Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph Adenomas
https://clinicaltrials.gov/ct2/show/NCT00929669

Nov 28th, 2017 - Gonadotroph adenomas are the most common pituitary macroadenomas. Currently no medical treatment as been found that decreases the size of these adenomas, so surgery is the only treatment. The reason to think that pasireotide might affect gonadotro...

Value of 25 mcg Cortrosyn Stimulation Test
https://clinicaltrials.gov/ct2/show/NCT01428336

Jul 25th, 2017 - The study consisted of two groups of adult patients 18 to 65 years of age. The first group (G1, n=10) included patients with hypothalamic/pituitary disease with at least one pituitary axis deficiency other than ACTH deficiency. The patients had th...

see more →

News  1 results

Fast Five Quiz: Test Your Knowledge of Acromegaly
https://reference.medscape.com/viewarticle/875763_6

Sep 16th, 2020 - Answer 5/5 Which of the following is accurate regarding treatment of acromegaly? Your peers chose: Pharmacologic therapy is the first-line treatment for acromegaly 0% Radiation therapy is routinely indicated for most patients with acromegaly 0% Fo...

see more →